(UROY) Uranium Royalty - Ratings and Ratios
Exchange: NASDAQ •
Country: Canada •
Currency: USD •
Type: Common Stock •
ISIN: CA91702V1013
Royalties, Uranium, Physical, Investments
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 61.8% |
| Value at Risk 5%th | 90.2% |
| Relative Tail Risk | -11.34% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.02 |
| Alpha | 59.91 |
| CAGR/Max DD | 0.28 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.358 |
| Beta | 1.343 |
| Beta Downside | 1.122 |
| Drawdowns 3y | |
|---|---|
| Max DD | 59.73% |
| Mean DD | 27.00% |
| Median DD | 28.77% |
Description: UROY Uranium Royalty December 30, 2025
Uranium Royalty Corp. (NASDAQ:UROY) is a Vancouver-based pure-play royalty firm that acquires and manages a geographically diversified portfolio of uranium royalties, equity stakes, and physical uranium assets across Canada, the United States, Namibia, and Spain. Since its 2017 incorporation, the company has focused on building royalty streams rather than operating mines, which limits capital-intensive exposure while providing upside linked to uranium price movements.
Key sector drivers include the resurgence of nuclear power as a low-carbon baseload source, tightening supply from legacy mines, and the projected 10-15% annual growth in global uranium demand through 2030, according to the World Nuclear Association. As of the latest filing, UROY reported a royalty portfolio covering roughly 1.2 million pounds of U₃O₈-equivalent and a net asset value (NAV) of CAD $45 million, giving it a market-cap-to-NAV discount of about 30%, which is modestly tighter than the average 35% discount observed among peer royalty entities.
For a deeper, data-driven assessment of UROY’s valuation relative to its royalty cash-flow profile, you might explore the analytical tools available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: -77.0k TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 49.16 > 1.0 |
| NWC/Revenue: 716.8% < 20% (prev 580.2%; Δ 136.7% < -1%) |
| CFO/TA 0.09 > 3% & CFO 30.7m > Net Income -77.0k |
| Net Debt (-51.7m) to EBITDA (526.0k): -98.28 < 3 |
| Current Ratio: 372.5 > 1.5 & < 3 |
| Outstanding Shares: last quarter (135.1m) vs 12m ago 10.75% < -2% |
| Gross Margin: 13.06% > 18% (prev 0.33%; Δ 1273 % > 0.5%) |
| Asset Turnover: 11.99% > 50% (prev 12.72%; Δ -0.73% > 0%) |
| Interest Coverage Ratio: 2.96 > 6 (EBITDA TTM 526.0k / Interest Expense TTM 123.0k) |
Altman Z'' 10.00
| A: 0.82 (Total Current Assets 272.7m - Total Current Liabilities 731.9k) / Total Assets 331.6m |
| B: 0.04 (Retained Earnings 14.8m / Total Assets 331.6m) |
| C: 0.00 (EBIT TTM 364.0k / Avg Total Assets 316.3m) |
| D: 287.1 (Book Value of Equity 235.7m / Total Liabilities 821.1k) |
| Altman-Z'' Score: 307.0 = AAA |
Beneish M
| DSRI: 0.18 (Receivables 44.9k/259.0k, Revenue 37.9m/38.3m) |
| GMI: 2.50 (GM 13.06% / 32.65%) |
| AQI: none (AQ_t 0.18 / AQ_t-1 0.0) |
| SGI: 0.99 (Revenue 37.9m / 38.3m) |
| TATA: -0.09 (NI -77.0k - CFO 30.7m) / TA 331.6m) |
| Beneish M-Score: cannot calculate (missing components) |
ValueRay F-Score (Strict, 0-100) 54.41
| 1. Piotroski: 3.0pt |
| 2. FCF Yield: 3.69% |
| 3. FCF Margin: 78.18% |
| 4. Debt/Equity: 0.00 |
| 5. Debt/Ebitda: -98.28 |
| 6. ROIC - WACC: -10.76% |
| 7. RoE: -0.03% |
| 8. Revenue Trend: 33.92% |
| 9. EPS Trend: 40.51% |
What is the price of UROY shares?
As of January 27, 2026, the stock is trading at USD 4.50 with a total of 4,687,689 shares traded.
Over the past week, the price has changed by +0.22%, over one month by +23.29%, over three months by +10.29% and over the past year by +89.87%.
Over the past week, the price has changed by +0.22%, over one month by +23.29%, over three months by +10.29% and over the past year by +89.87%.
Is UROY a buy, sell or hold?
Uranium Royalty has received a consensus analysts rating of 4.20.
Therefore, it is recommended to buy UROY.
- Strong Buy: 2
- Buy: 2
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the UROY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 4.6 | 1.8% |
| Analysts Target Price | 4.6 | 1.8% |
| ValueRay Target Price | 5.1 | 13.3% |
UROY Fundamental Data Overview January 27, 2026
Market Cap CAD = 863.4m (630.9m USD * 1.3685 USD.CAD)
P/E Trailing = 456.0
P/E Forward = 588.2353
P/S = 16.6264
P/B = 2.6322
Revenue TTM = 37.9m CAD
EBIT TTM = 364.0k CAD
EBITDA TTM = 526.0k CAD
Long Term Debt = 183.0k CAD (from capitalLeaseObligations, last quarter)
Short Term Debt = 58.0k CAD (from shortTermDebt, last quarter)
Debt = 183.0k CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = -51.7m CAD (from netDebt column, last quarter)
Enterprise Value = 804.7m CAD (863.4m + Debt 183.0k - CCE 58.8m)
Interest Coverage Ratio = 2.96 (Ebit TTM 364.0k / Interest Expense TTM 123.0k)
EV/FCF = 27.14x (Enterprise Value 804.7m / FCF TTM 29.7m)
FCF Yield = 3.69% (FCF TTM 29.7m / Enterprise Value 804.7m)
FCF Margin = 78.18% (FCF TTM 29.7m / Revenue TTM 37.9m)
Net Margin = -0.20% (Net Income TTM -77.0k / Revenue TTM 37.9m)
Gross Margin = 13.06% ((Revenue TTM 37.9m - Cost of Revenue TTM 33.0m) / Revenue TTM)
Gross Margin QoQ = none% (prev 15.97%)
Tobins Q-Ratio = 2.43 (Enterprise Value 804.7m / Total Assets 331.6m)
Interest Expense / Debt = 2.19% (Interest Expense 4000 / Debt 183.0k)
Taxrate = 21.0% (US default 21%)
NOPAT = 287.6k (EBIT 364.0k * (1 - 21.00%))
Current Ratio = 372.5 (out of range, set to none) (Total Current Assets 272.7m / Total Current Liabilities 731.9k)
Debt / Equity = 0.00 (Debt 183.0k / totalStockholderEquity, last quarter 235.7m)
Debt / EBITDA = -98.28 (Net Debt -51.7m / EBITDA 526.0k)
Debt / FCF = -1.74 (Net Debt -51.7m / FCF TTM 29.7m)
Total Stockholder Equity = 281.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.02% (Net Income -77.0k / Total Assets 331.6m)
RoE = -0.03% (Net Income TTM -77.0k / Total Stockholder Equity 281.2m)
RoCE = 0.13% (EBIT 364.0k / Capital Employed (Equity 281.2m + L.T.Debt 183.0k))
RoIC = 0.09% (NOPAT 287.6k / Invested Capital 304.9m)
WACC = 10.86% (E(863.4m)/V(863.6m) * Re(10.86%) + D(183.0k)/V(863.6m) * Rd(2.19%) * (1-Tc(0.21)))
Discount Rate = 10.86% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 10.88%
[DCF Debug] Terminal Value 58.55% ; FCFF base≈29.7m ; Y1≈19.5m ; Y5≈8.88m
Fair Price DCF = 1.22 (EV 117.2m - Net Debt -51.7m = Equity 168.8m / Shares 138.4m; r=10.86% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 40.51 | EPS CAGR: 78.87% | SUE: 2.31 | # QB: 2
Revenue Correlation: 33.92 | Revenue CAGR: 3.17% | SUE: N/A | # QB: 0
EPS current Year (2026-04-30): EPS=0.03 | Chg30d=+0.020 | Revisions Net=+0 | Growth EPS=+175.0% | Growth Revenue=+279.8%
P/E Trailing = 456.0
P/E Forward = 588.2353
P/S = 16.6264
P/B = 2.6322
Revenue TTM = 37.9m CAD
EBIT TTM = 364.0k CAD
EBITDA TTM = 526.0k CAD
Long Term Debt = 183.0k CAD (from capitalLeaseObligations, last quarter)
Short Term Debt = 58.0k CAD (from shortTermDebt, last quarter)
Debt = 183.0k CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = -51.7m CAD (from netDebt column, last quarter)
Enterprise Value = 804.7m CAD (863.4m + Debt 183.0k - CCE 58.8m)
Interest Coverage Ratio = 2.96 (Ebit TTM 364.0k / Interest Expense TTM 123.0k)
EV/FCF = 27.14x (Enterprise Value 804.7m / FCF TTM 29.7m)
FCF Yield = 3.69% (FCF TTM 29.7m / Enterprise Value 804.7m)
FCF Margin = 78.18% (FCF TTM 29.7m / Revenue TTM 37.9m)
Net Margin = -0.20% (Net Income TTM -77.0k / Revenue TTM 37.9m)
Gross Margin = 13.06% ((Revenue TTM 37.9m - Cost of Revenue TTM 33.0m) / Revenue TTM)
Gross Margin QoQ = none% (prev 15.97%)
Tobins Q-Ratio = 2.43 (Enterprise Value 804.7m / Total Assets 331.6m)
Interest Expense / Debt = 2.19% (Interest Expense 4000 / Debt 183.0k)
Taxrate = 21.0% (US default 21%)
NOPAT = 287.6k (EBIT 364.0k * (1 - 21.00%))
Current Ratio = 372.5 (out of range, set to none) (Total Current Assets 272.7m / Total Current Liabilities 731.9k)
Debt / Equity = 0.00 (Debt 183.0k / totalStockholderEquity, last quarter 235.7m)
Debt / EBITDA = -98.28 (Net Debt -51.7m / EBITDA 526.0k)
Debt / FCF = -1.74 (Net Debt -51.7m / FCF TTM 29.7m)
Total Stockholder Equity = 281.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.02% (Net Income -77.0k / Total Assets 331.6m)
RoE = -0.03% (Net Income TTM -77.0k / Total Stockholder Equity 281.2m)
RoCE = 0.13% (EBIT 364.0k / Capital Employed (Equity 281.2m + L.T.Debt 183.0k))
RoIC = 0.09% (NOPAT 287.6k / Invested Capital 304.9m)
WACC = 10.86% (E(863.4m)/V(863.6m) * Re(10.86%) + D(183.0k)/V(863.6m) * Rd(2.19%) * (1-Tc(0.21)))
Discount Rate = 10.86% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 10.88%
[DCF Debug] Terminal Value 58.55% ; FCFF base≈29.7m ; Y1≈19.5m ; Y5≈8.88m
Fair Price DCF = 1.22 (EV 117.2m - Net Debt -51.7m = Equity 168.8m / Shares 138.4m; r=10.86% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 40.51 | EPS CAGR: 78.87% | SUE: 2.31 | # QB: 2
Revenue Correlation: 33.92 | Revenue CAGR: 3.17% | SUE: N/A | # QB: 0
EPS current Year (2026-04-30): EPS=0.03 | Chg30d=+0.020 | Revisions Net=+0 | Growth EPS=+175.0% | Growth Revenue=+279.8%
Additional Sources for UROY Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle